Conference founders Marco Romanelli, M.D., Ph.D., and Paolo Romanelli, M.D., center left and right, with Galilei Symposium attendees.

Transatlantic Conference Highlights Major Issues in Dermatology

The XI International Dermatologic Galilei Symposium — an annual conference jointly sponsored by the departments of dermatology at the University of Miami Miller School of Medicine and the University of Pisa — was held for the first time in Miami March 28-30. Twenty faculty members traveled from Europe and the Middle East to attend the conference, which covered some of the most important current topics in dermatology.

Read more »

Angelina Meza-Suarez, RN (left) and Monica Perez, RN, next to a hyperbaric chamber.

Hyperbaric Nurses Day, April 3, Highlights the Critical Role These Professionals Play

Hyperbaric medicine can be a ‘game changer’ for many people, facilitating their healing, speeding their recovery, and providing what for many is a one-time opportunity to experience optimal outcomes after a diving accident, radiation injury, surgery involving skin flaps, and many more indications.

Read more »

Miller School of Medicine Rises in NIH Research Grant Funding

The Miller School of Medicine received $120.7 million in research grants from the National Institutes of Health in Federal Fiscal Year 2017 — a $9.5 million increase over the school’s FFY 2016 total. According to the national rankings of medical schools based on data compiled by the Blue Ridge Institute for Medical Research, that total made the Miller School the No. 1 NIH-funded institution in Florida.

Read more »

Stromal cells in the laboratory.

Mesenchymal Stromal Cells Shown to Prevent Lung and Skin Fibrosis, Restore Wound Healing

A cross-disciplinary group of researchers at the University of Miami Miller School of Medicine has found that allogeneic adipose-derived mesenchymal stromal cells (ASCs) will prevent lung and skin fibrosis, and restore wound healing.

Read more »

The study is one of the first revealing the underlying molecular mechanisms responsible for pathophysiology of diabetic foot ulcers.

Researchers Identify Possible Treatment and Diagnostic Targets for Diabetic Foot Ulcers

Diabetic foot ulcers are one of the major complications of Type 2 diabetes, with very limited treatment options. Now a group of NIH-funded researchers at the University of Miami Miller School of Medicine has identified major new mechanisms that not only play an important role in the inhibition of the wound healing, but also point to a new direction for therapeutic and diagnostic development.

Read more »